Alaunos Therapeutics | Los Gastos Financieros De La Deuda



Interest Expense On Debt Cambio Fecha
Alaunos Therapeutics USD 0 0 2023-12
Amgen USD 747M 29M 2024-12
AstraZeneca 429M 28M 2024-12
Baxter International USD 100M 1000K 2024-12
Biogen USD 60M 200K 2024-12
Bioline Rx 1.62M 460K 2024-09
Bristol-Myers Squibb USD 496M 9M 2024-12
Celltrion KRW 18.38B 907.05M 2024-09
Corcept Therapeutics 6M 6M 2024-06
Cspc Pharmaceutical 11.32M 4.55M 2024-09
Dianthus Therapeutics 4.44M 4.44M 2024-09
Ecofibre AUD 761K 773K 2024-06
Gilead Sciences USD 248M 10M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Incyte USD 419K 355K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
J&J USD 137M 56M 2024-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Medical Developments International AUD 21K 23K 2024-06
Merck USD 328M 2M 2024-12
Neuren Pharmaceuticals 0 0 2024-06
Novartis USD 275M 11M 2024-12
Pfizer USD 739M 45M 2024-12
PTC Therapeutics USD 42.11M 1.09M 2024-09
Qiagen NV USD 11.14M 337K 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sartorius 48.9M 41.76M 2024-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
TG Therapeutics USD 10.83M 6.86M 2024-09
Tilray USD 7.77M 2.08M 2024-11
Zz Pientze Pharmaceu 9.17M 60K 2024-09



Alaunos Therapeutics Los Gastos Financieros De La Deuda - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.